Search

EHA response to the EU’s Pharma Revision

Last week, the European Affairs team finalised EHA's response to the proposed revision of the EU (European Union) Pharmaceutical Legislation. In April 2023, the European Commission published a proposed Directive and Regulation to replace the current, outdated legal framework.

Read more

Research Committee

Current committee members
Brian Huntly, United Kingdom (Chair)
Ruud Delwel, The Netherlands (Vice-Chair)
Dominique Bonnet, United Kingdom (EHA Board representative)
Shai Izraeli, Israel (TRTH representative)
David Kent, United Kingdom (Fellowships and Grants representative)
Alba Maiques Diaz, Spain (YoungEHA representative)
Martina Muckenthaler, Germany (HemaSphere representative)
Andreas Trumpp, Germany (Supernumerary…

Read more

European Hematology Association publishes new journal with Wolters Kluwer

The European Hematology Association, the largest Europe-based association of hematologists, launched its new journal HemaSphere with publisher Wolters Kluwer at the 22nd Annual Congress of EHA in Madrid.

Read more

Daratumumab Shows Remarkable Benefit in Relapsed or Refractory Multiple Myeloma in the POLLUX Study

Daratumumab is a fully human monoclonal antibody that binds to a novel target on myeloma cells.

Read more

Virtual: EHA-PTHiT Hematology Mini Tutorial - a report

VIRTUAL: EHA-PTHiT Hematology Mini Tutorial

April 12 -13, 2021

Meeting Chairs:

Prof G Gaidano (European Hematology Association)
Prof I Hus (Polish Society of Hematology and Transfusion)
Prof T Robak (Polish Society of Hematology and Transfusion)
As a prelude to the full Tutorial planned for later this…

Read more

In Memoriam Anneke Brand

Picture: Ineke Oostveen

 

On Sunday, November 21, 2021, Anneke Brand, MD, PhD, emeritus professor at Leiden University Medical Center (LUMC), passed away suddenly. The European Hematology Association community is deeply saddened by Anneke’s passing.

Read more

Improved survival for adult Acute Lymphoblastic Leukemia (ALL) patients

Historical survival for patients 18-45 years with ALL is approximately 40 %. However the event free survival for ALL patients 18-45 years has improved to 73% following implementation of the NOPHO ALL2008 protocol in July 2008.

Read more

EHA Research Conference 2024

Dates: March 18-21, 2024
Location: Borovets, Bulgaria
Chairs: Anna Kabanova, Martina Muckenthaler, Andreas Trumpp, Simon Haas, Jean-Emmanuel Sarry, Achille Iolascon, Britta Will and Brian Huntly

Registration is closed

EHA is proud to announce the second edition of the EHA Research Conference, titled "Molecular vulnerabilities and…

Read more